SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2006 / Cilt: 34 - Sayı: 2

What is new in guidelines for chronic heart failure?

Kronik kalp yetersizliği kılavuzlarında neler değişti?

Barış İLERİGELEN
Pages
131–136
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review summarizes those changes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recent guidelines for the evaluation and management of heart failure have come up with important changes in the approaches to the diagnosis and treatment of this disorder.
📊
Key Findings & Data:Recent guidelines for the evaluation and management of heart failure have come up with important changes in the approaches to the diagnosis and treatment of this disorder.
💡
Conclusion & Impact:This review summarizes those changes.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recent guidelines for the evaluation and management of heart failure have come up with important changes in the approaches to the diagnosis and treatment of this disorder. This review summarizes those changes.

Özet

Son yıllarda yayımlanan kalp yetersizliği kılavuzlarında tanı ve tedavi yaklaşımlarında önemli değişiklikler olmuştur. Bu derlemenin amacı söz konusu değişiklikleri özetlemektir.

🔖

Cite This Article

İLERİGELEN, B. (2022). What is new in guidelines for chronic heart failure?. Türk Kardiyoloji Derneği Arşivi, Cilt: 34 - Sayı: 2, 131–136. https://ajindex.com/articles/633726

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Johnstone DE, Abdulla A, Arnold JM, Bernstein V, Bourassa M, Brophy J, et al. Diagnosis and management of heart failure. Canadian Cardiovascular Society. Can J Cardiol 1994;10:635-54
  2. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995;26:1376-98
  3. Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology. Eur Heart J 1995;16:741-51
  4. The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 1997;18:736-53
  5. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35
  6. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325: 303-10
  7. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325:293-302
  8. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91
  9. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77
  10. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-52
  11. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986; 73:503-10
  12. The effect of digoxin on mortality and morbidity in patients with heart failure. The digitalis investigation group. N Engl J Med 1997;336:525-33
  13. Packer M, Bristow MR, Cohn